Unicycive Therapeutics, Inc., a clinical stage biotechnology company developing therapies for patients with kidney disease, announced that Shalabh Gupta, M.D., Chief Executive Officer will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.
September 7, 2021
· 1 min read